Article
Polymorphisms in catechol-O-methyltransferase modify treatment effects of aspirin on risk of cardiovascular disease.
Arteriosclerosis, thrombosis, and vascular biology - 1 Sept 2014
Hall Kathryn T, Nelson Christopher P, Davis Roger B, Buring Julie E, Kirsch Irving, Mittleman Murray A, Loscalzo Joseph, Samani Nilesh J, Ridker Paul M, Kaptchuk Ted J, Chasman Daniel I
Abstract excerpt
OBJECTIVE: Catechol-O-methyltransferase (COMT), a key enzyme in catecholamine metabolism, is implicated in cardiovascular, sympathetic, and endocrine pathways. This study aimed to confirm preliminary association of COMT genetic variation with incident cardiovascular disease (CVD). It further aimed to evaluate whether aspirin, a commonly used CVD prevention agent, modified the potential association of COMT with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
